Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for

Manoj Sigdel1, Binod Kumar Yadav, Prajwal Gyawali

  • 1Department of Biochemistry, Manipal College of Medical Sciences, Pokhara, Nepal. manoj.sigdel@hotmail.com

BMC Research Notes
|November 20, 2012
PubMed

Insights

Non-high-density lipoprotein cholesterol (non-HDL-C) and high-density lipoprotein cholesterol (HDL-C) are superior predictors of myocardial infarction (MI) compared to low-density lipoprotein cholesterol (LDL-C). These lipid measures do not require fasting, offering a more convenient assessment of cardiovascular risk.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Biochemistry
  • Lipid Metabolism

Background:

  • Serum total cholesterol (TC) and LDL cholesterol (LDL-C) are standard clinical markers for cardiovascular risk assessment.
  • Non-HDL cholesterol (non-HDL-C) is an alternative lipid measure, calculated as TC minus HDL-C.
  • Unlike LDL-C, non-HDL-C and HDL-C do not necessitate a fasting blood sample.

Purpose of the Study:

  • To compare the efficacy of non-HDL-C versus LDL-C in predicting myocardial infarction (MI).
  • To evaluate lipid parameters as risk factors for MI in a hospital-based population.

Main Methods:

  • A cross-sectional study involving 51 MI cases and 51 controls.
  • MI diagnosis based on clinical history, ECG, and biochemical parameters.
  • Lipid profile analysis including calculation of non-HDL-C (TC - HDL-C) from fasting blood samples.

Main Results:

  • Dyslipidemia was significantly more prevalent in MI cases (42) than in controls (20).
  • HDL-C showed the strongest association with MI (OR 5.85), followed by non-HDL-C (OR 3.77) and LDL-C (OR 2.70).
  • Non-HDL-C demonstrated higher sensitivity and specificity than LDL-C for MI prediction, with a greater area under the receiver operating curve.

Conclusions:

  • HDL-C and non-HDL-C are more effective than LDL-C in discriminating MI risk.
  • Non-fasting measurement of HDL-C and non-HDL-C offers a practical alternative to fasting-based LDL-C testing for MI risk assessment.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...